المؤلفون: Ascierto, PA, Dréno, B, Larkin, J, Ribas, A, Liszkay, G, Maio, M, Mandalà, M, Demidov, L, Stroyakovskiy, D, Thomas, L, de la Cruz-Merino, L, Atkinson, V, Dutriaux, C, Garbe, C, Hsu, J, Jones, S, Li, H, McKenna, E, Voulgari, A, McArthur, GA

المساهمون: Larkin, James

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols, Azetidines, Follow-Up Studies, Humans, Melanoma, Mutation, Piperidines, Proto-Oncogene Proteins B-raf, Skin Neoplasms, Vemurafenib

جغرافية الموضوع: United States

وصف الملف: Print; 5235; application/pdf

العلاقة: 1078-0432.CCR-21-0809; Clinical Cancer Research, 2021, 27 (19), pp. 5225 - 5235; https://repository.icr.ac.uk/handle/internal/5284Test

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-21-0809Test
https://repository.icr.ac.uk/handle/internal/5284Test

المؤلفون: Dréno, B, Ascierto, PA, Atkinson, V, Liszkay, G, Maio, M, Mandalà, M, Demidov, L, Stroyakovskiy, D, Thomas, L, de la Cruz-Merino, L, Dutriaux, C, Garbe, C, Bartley, K, Karagiannis, T, Chang, I, Rooney, I, Koralek, DO, Larkin, J, McArthur, GA, Ribas, A

المساهمون: Larkin, James

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols, Azetidines, Double-Blind Method, Female, Humans, Longitudinal Studies, Male, Melanoma, Mutation, Piperidines, Placebos, Proto-Oncogene Proteins B-raf, Quality of Life, Vemurafenib

جغرافية الموضوع: England

وصف الملف: Print-Electronic; 784; application/pdf

العلاقة: bjc2017488; British Journal of Cancer, 2018, 118 (6), pp. 777 - 784; https://repository.icr.ac.uk/handle/internal/5296Test

الإتاحة: https://doi.org/10.1038/bjc.2017.488Test
https://repository.icr.ac.uk/handle/internal/5296Test

المؤلفون: Dreno B., Ascierto P. A., Atkinson V., Liszkay G., Maio M., Mandala M., Demidov L., Stroyakovskiy D., Thomas L., De La Cruz-Merino L., Dutriaux C., Garbe C., Bartley K., Karagiannis T., Chang I., Rooney I., Koralek D. O., Larkin J., McArthur G. A., Ribas A.

المساهمون: Dreno, B., Ascierto, P. A., Atkinson, V., Liszkay, G., Maio, M., Mandala, M., Demidov, L., Stroyakovskiy, D., Thomas, L., De La Cruz-Merino, L., Dutriaux, C., Garbe, C., Bartley, K., Karagiannis, T., Chang, I., Rooney, I., Koralek, D. O., Larkin, J., Mcarthur, G. A., Ribas, A.

مصطلحات موضوعية: BRAF inhibitor, Cobimetinib, EORTC QLQ-C30, HRQOL, MEK inhibitor, Metastatic melanoma, Vemurafenib, Antineoplastic Combined Chemotherapy Protocol, Azetidine, Double-Blind Method, Female, Human, Longitudinal Studie, Male, Melanoma, Piperidine, Placebo, Proto-Oncogene Proteins B-raf, Quality of Life, Mutation

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29438370; info:eu-repo/semantics/altIdentifier/wos/WOS:000427945800016; volume:118; issue:6; firstpage:777; lastpage:784; numberofpages:8; journal:BRITISH JOURNAL OF CANCER; http://hdl.handle.net/11365/1083773Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85044192869; http://www.nature.com/bjc/index.htmlTest

الإتاحة: https://doi.org/10.1038/bjc.2017.488Test
http://hdl.handle.net/11365/1083773Test
http://www.nature.com/bjc/index.htmlTest

المؤلفون: Kandolf Sekulovic, L., Peris, K., Hauschild, A., Stratigos, A., Grob, J. -J., Nathan, P., Dummer, R., Forsea, A. -M., Hoeller, C., Gogas, H., Demidov, L., Lebbe, C., Blank, C., Olah, J., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Hansson, J., Rutkowski, P., Krajsova, I., Bylaite-Bucinskiene, M., Zalaudek, I., Maric-Brozic, J., Babovic, N., Banjin, M., Putnik, K., Weinlich, G., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Kukushkina, M., De La Cruz Merino, L., Ymeri, A., Risteski, M., Garbe, C.

المساهمون: Kandolf Sekulovic, L., Peris, K., Hauschild, A., Stratigos, A., Grob, J. -J., Nathan, P., Dummer, R., Forsea, A. -M., Hoeller, C., Gogas, H., Demidov, L., Lebbe, C., Blank, C., Olah, J., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Hansson, J., Rutkowski, P., Krajsova, I., Bylaite-Bucinskiene, M., Zalaudek, I., Maric-Brozic, J., Babovic, N., Banjin, M., Putnik, K., Weinlich, G., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Kukushkina, M., De La Cruz Merino, L., Ymeri, A., Risteski, M., Garbe, C.

مصطلحات موضوعية: Acce, Health expenditure per capita, Human development index, Immunooncology, Innovative medicine, Metastatic melanoma, Targeted therapy, Treatment, Acrylonitrile, Aniline Compound, Antibodies, Monoclonal, Humanized, Europe, Female, Health Services Accessibility, Healthcare Disparitie, Human, Immunotherapy, Male, Melanoma, Programmed Cell Death 1 Receptor, Proto-Oncogene Proteins B-raf, Reimbursement Mechanism, Skin Neoplasm, Therapies, Investigational, Oncology, Cancer Research

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28264791; info:eu-repo/semantics/altIdentifier/wos/WOS:000399856400040; volume:75; firstpage:313; lastpage:322; numberofpages:10; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11368/2923064Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85014383793; http://www.ejcancer.com/article/S0959-8049Test(17)30069-2/abstract

الإتاحة: https://doi.org/10.1016/j.ejca.2017.01.012Test
http://hdl.handle.net/11368/2923064Test
http://www.ejcancer.com/article/S0959-8049Test(17)30069-2/abstract

المؤلفون: Ascierto P. A., Dreno B., Larkin J., Ribas A., Liszkay G., Maio M., Mandala M., Demidov L., Stroyakovskiy D., Thomas L., de la Cruz-Merino L., Atkinson V., Dutriaux C., Garbe C., Hsu J., Jones S., Li H., McKenna E., Voulgari A., McArthur G. A.

المساهمون: Ascierto, P. A., Dreno, B., Larkin, J., Ribas, A., Liszkay, G., Maio, M., Mandala, M., Demidov, L., Stroyakovskiy, D., Thomas, L., de la Cruz-Merino, L., Atkinson, V., Dutriaux, C., Garbe, C., Hsu, J., Jones, S., Li, H., Mckenna, E., Voulgari, A., Mcarthur, G. A.

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocol, Azetidine, Follow-Up Studie, Human, Mutation, Piperidine, Proto-Oncogene Proteins B-raf, Vemurafenib, Melanoma, Skin Neoplasms

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34158360; info:eu-repo/semantics/altIdentifier/wos/WOS:000704224400009; volume:27; issue:19; firstpage:5225; lastpage:5235; numberofpages:11; journal:CLINICAL CANCER RESEARCH; https://hdl.handle.net/11365/1225914Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85117784071

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-21-0809Test
https://hdl.handle.net/11365/1225914Test

المؤلفون: Schadendorf D., Di Giacomo A. M., Demidov L., Merelli B., Bondarenko I., Ascierto P. A., Herbert C., Mackiewicz A., Rutkowski P., Guminski A., Goodman G. R., Simmons B., Ye C., Hong A., Lewis K.

المساهمون: Schadendorf, D., Di Giacomo, A. M., Demidov, L., Merelli, B., Bondarenko, I., Ascierto, P. A., Herbert, C., Mackiewicz, A., Rutkowski, P., Guminski, A., Goodman, G. R., Simmons, B., Ye, C., Hong, A., Lewis, K.

مصطلحات موضوعية: Adjuvant treatment, BRAF, Health-related quality of life, Resected melanoma, Vemurafenib, Adolescent, Adult, Aged, 80 and over, Anorexia, Antineoplastic Agent, Cognitive Dysfunction, Fatigue, Female, Human, Logistic Model, Male, Melanoma, Middle Aged, Pain, Proto-Oncogene Proteins B-raf, Skin Neoplasm, Young Adult, Chemotherapy, Adjuvant, Dermatologic Surgical Procedure, Quality of Life

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31704549; info:eu-repo/semantics/altIdentifier/wos/WOS:000499645600019; volume:123; firstpage:155; lastpage:161; numberofpages:7; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11365/1119739Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85074348441

الإتاحة: https://doi.org/10.1016/j.ejca.2019.09.019Test
http://hdl.handle.net/11365/1119739Test

المؤلفون: Ascierto P. A., McArthur G. A., Dreno B., Atkinson V., Liszkay G., Di Giacomo A. M., Mandala M., Demidov L., Stroyakovskiy D., Thomas L., de la Cruz-Merino L., Dutriaux C., Garbe C., Yan Y., Wongchenko M., Chang I., Hsu J. J., Koralek D. O., Rooney I., Ribas A., Larkin J.

المساهمون: Ascierto, P. A., Mcarthur, G. A., Dreno, B., Atkinson, V., Liszkay, G., Di Giacomo, A. M., Mandala, M., Demidov, L., Stroyakovskiy, D., Thomas, L., de la Cruz-Merino, L., Dutriaux, C., Garbe, C., Yan, Y., Wongchenko, M., Chang, I., Hsu, J. J., Koralek, D. O., Rooney, I., Ribas, A., Larkin, J.

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocol, Azetidine, Biomarkers, Tumor, Double-Blind Method, Melanoma, Neoplasm Metastasi, Neoplasm Staging, Piperidine, Prognosi, Proto-Oncogene Proteins B-raf, Skin Neoplasm, Sulfonamide, Survival Rate [MeSH]

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27480103; info:eu-repo/semantics/altIdentifier/wos/WOS:000382398700039; volume:17; issue:9; firstpage:1248; lastpage:1260; numberofpages:13; journal:THE LANCET ONCOLOGY; https://hdl.handle.net/11365/1233346Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84994499942; https://www.sciencedirect.com/science/article/pii/S147020451630122XTest

الإتاحة: https://doi.org/10.1016/S1470-2045Test(16)30122-X
https://hdl.handle.net/11365/1233346Test
https://www.sciencedirect.com/science/article/pii/S147020451630122XTest

المؤلفون: Ascierto, PA, McArthur, GA, Dréno, B, Atkinson, V, Liszkay, G, Di Giacomo, AM, Mandalà, M, Demidov, L, Stroyakovskiy, D, Thomas, L, de la Cruz-Merino, L, Dutriaux, C, Garbe, C, Yan, Y, Wongchenko, M, Chang, I, Hsu, JJ, Koralek, DO, Rooney, I, Ribas, A, Larkin, J

المساهمون: Larkin, James

مصطلحات موضوعية: Humans, Melanoma, Skin Neoplasms, Neoplasm Metastasis, Sulfonamides, Azetidines, Piperidines, Indoles, Proto-Oncogene Proteins B-raf, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Staging, Prognosis, Survival Rate, Follow-Up Studies, Double-Blind Method, Mutation, Adult, Aged, 80 and over, Middle Aged, Female, Male, Young Adult, Biomarkers, Tumor, Vemurafenib

وصف الملف: Print-Electronic; 1260; application/pdf

العلاقة: The Lancet. Oncology, 2016, 17 (9), pp. 1248 - 1260; https://repository.icr.ac.uk/handle/internal/664Test

الإتاحة: https://doi.org/10.1016/s1470-2045Test(16)30122-x
https://repository.icr.ac.uk/handle/internal/664Test

المؤلفون: Ketty Peris, Lev V. Demidov, Lars Bastholt, J.-J. Grob, Paul Nathan, M. Banjin, M. Kukushkina, Alexandros Stratigos, A.M. Forsea, A. Ymeri, Matilda Bylaite-Bucinskiene, Christoph Hoeller, A. Zhukavets, V. Todorovic, G. Weinlich, Claus Garbe, K. Putnik, L. Kandolf Sekulovic, Piotr Rutkowski, M. Risteski, K. Kirov, Iris Zalaudek, J. Ocvirk, Reinhard Dummer, D. Herceg, J. Maric-Brozic, Helen Gogas, Ricardo Vieira, Judit Oláh, Ivana Krajsová, N. Babovic, L. De La Cruz Merino, C. Blank, Johan Hansson, Bart Neyns, Axel Hauschild, C. Lebbé

المساهمون: Laboratory of Molecullar and Cellular Therapy, Laboratory for Medical and Molecular Oncology, Clinical sciences, [Sekulovic, L. Kandolf] Mil Med Acad, Fac Med, Dept Dermatol, Belgrade, Serbia, [Peris, K.] Univ Cattolica Sacro Cuore, Inst Dermatol, Rome, Italy, [Hauschild, A.] Univ Hosp Schleswig Holstein UKSH, Dept Dermatol, Campus Kiel, Kiel, Germany, [Stratigos, A.] Univ Athens, Athens, Greece, [Gogas, H.] Univ Athens, Athens, Greece, [Grob, J. -J.] Hop la Timone, Serv Dermatol & Cancerol Cutanee, Marseille, France, [Nathan, P.] Mt Vernon Canc Ctr, Northwood, Middx, England, [Dummer, R.] Univ Hosp, Univ Spital Zurich, Skin Canc Ctr, Zurich, Switzerland, [Forsea, A. -M.] Carol Davila Univ Med & Pharm, Elias Univ Hosp Bucharest, Bucharest, Romania, [Hoeller, C.] Med Univ Vienna, Dept Dermatol, Vienna, Austria, [Demidov, L.] NN Blokhin Russian Canc Res Ctr, Moscow, Russia, [Lebbe, C.] Hosp St Louis, APHP, Paris, France, [Blank, C.] Netherland Canc Inst, Amsterdam, Netherlands, [Olah, J.] Univ Szeged, Dept Dermatol & Allergol, Szeged, Hungary, [Bastholt, L.] Odense Univ Hosp, Dept Oncol, Odense, Denmark, [Herceg, D.] Univ Hosp Zagreb, Dept Oncol, Zagreb, Croatia, [Neyns, B.] VUB, Univ Ziekenhuis Brussel, Dept Med Oncol, Brussels, Belgium, [Vieira, R.] Univ Coimbra, Fac Med, Dept Dermatol, Coimbra, Portugal, [Hansson, J.] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden, [Hansson, J.] Karolinska Univ Hosp Solna, Stockholm, Sweden, [Rutkowski, P.] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland, [Rutkowski, P.] Inst Oncol, Warsaw, Poland, [Krajsova, I.] Gen Teaching Hosp, Prague, Czech Republic, [Bylaite-Bucinskiene, M.] Vilnius Univ, Dept Dermatol, Vilnius, Lithuania, [Zalaudek, I.] Med Univ Graz, Div Dermatol & Venerol, Graz, Austria, [Maric-Brozic, J.] Univ Hosp Ctr Sestre Milosrdnice, Zagreb, Croatia, [Babovic, N.] Inst Oncol & Radiol Serbia, Belgrade, Serbia, [Banjin, M.] Univ Hosp Sarajevo, Dept Oncol, Sarajevo, Bosnia & Herceg, [Putnik, K.] North Estonia Med Ctr, Tallinn, Estonia, [Weinlich, G.] Med Univ Innsbruck, Dept Dermatol & Venerol & Allergy, Innsbruck, Austria, [Todorovic, V.] Clin Oncol & Radiotherapy, Podgorica, Montenegro, [Kirov, K.] Natl Canc Ctr, Clin Oncodermatol, Sofia, Bulgaria, [Ocvirk, J.] Inst Oncol Ljubljana, Ljubljana, Slovenia, [Zhukavets, A.] NN Alexandrov Natl Canc Ctr Belarus NCCB, Minsk, BELARUS, [Kukushkina, M.] Natl Canc Inst, Kiev, Ukraine, [De La Cruz Merino, L.] Hosp Univ Virgen Macarena, Dept Clin Oncol, Seville, Spain, [Ymeri, A.] Univ Hosp Mother Theresa, Tirana, Albania, [Risteski, M.] Univ Clin Radiotherapy & Oncol, Skopje, Macedonia, [Garbe, C.] Eberhard Karls Univ Tubingen, Dept Dermatol, Ctr Dermatooncol, Tubingen, Germany, Kandolf Sekulovic, L., Peris, K., Hauschild, A., Stratigos, A., Grob, J. -J., Nathan, P., Dummer, R., Forsea, A. -M., Hoeller, C., Gogas, H., Demidov, L., Lebbe, C., Blank, C., Olah, J., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Hansson, J., Rutkowski, P., Krajsova, I., Bylaite-Bucinskiene, M., Zalaudek, I., Maric-Brozic, J., Babovic, N., Banjin, M., Putnik, K., Weinlich, G., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Kukushkina, M., De La Cruz Merino, L., Ymeri, A., Risteski, M., Garbe, C.

المصدر: Kandolf Sekulovic, L, Peris, K, Hauschild, A, Stratigos, A, Grob, J J, Nathan, P, Dummer, R, Forsea, A M, Hoeller, C, Gogas, H, Demidov, L, Lebbe, C, Blank, C, Olah, J, Bastholt, L, Herceg, D, Neyns, B, Vieira, R, Hansson, J, Rutkowski, P, Krajsova, I, Bylaite-Bucinskiene, M, Zalaudek, I, Maric-Brozic, J, Babovic, N, Banjin, M, Putnik, K, Weinlich, G, Todorovic, V, Kirov, G K, Ocvirk, J, Zhukavets, A, Kukushkina, M, De La Cruz Merino, L, Ymeri, A, Risteski, M & Garbe, C 2017, ' More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments ', European Journal of Cancer, vol. 75, pp. 313-322 . https://doi.org/10.1016/j.ejca.2017.01.012Test

مصطلحات موضوعية: Human development index, Male, Cancer Research, Skin Neoplasms, Survival, medicine.medical_treatment, Access, Health expenditure per capita, Immunooncology, Innovative medicines, Metastatic melanoma, Targeted therapy, Treatment, Acrylonitrile, Aniline Compounds, Antibodies, Monoclonal, Humanized, Europe, Female, Health Services Accessibility, Healthcare Disparities, Humans, Immunotherapy, Melanoma, Programmed Cell Death 1 Receptor, Proto-Oncogene Proteins B-raf, Reimbursement Mechanisms, Therapies, Investigational, Oncology, Investigational, Reimbursement Mechanism, Melanoma/economics, Disparities, Immuno oncology, Medicines, 0302 clinical medicine, Diagnosis, Health care, Monoclonal, 030212 general & internal medicine, Healthcare Disparities/economics, Acce, Acrylonitrile/analogs & derivatives, Humanized, Proto-Oncogene Proteins B-raf/antagonists & inhibitors, Reimbursement, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Aniline Compound, Healthcare Disparitie, Health Services Accessibility/economics, 030220 oncology & carcinogenesis, Targeted therapy Health, Innovative medicine, Health-care, Settore MED/35 - MALATTIE CUTANEE E VENEREE, Treatment Immunooncology, Human, medicine.medical_specialty, Reimbursement Mechanisms/statistics & numerical data, Union, Antibodies, Europe/epidemiology, Malignant-melanoma, 03 medical and health sciences, Pharmacotherapy, Internal medicine, medicine, Skin Neoplasm, Human Development Index, Mortality, Therapies, Investigational/economics, Skin Neoplasms/economics, Health policy, business.industry, Cancer, medicine.disease, access, innovative medicines, metastatic melanoma, treatment, immunooncologytargeted therapyhealth expenditure per capita, human development index, Surgery, Immunotherapy/economics, Therapies, Aniline Compounds/economics, Skin cancer, business, Cancer incidence, Antibodies, Monoclonal, Humanized/economics

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f963ef44b2ff1f7ae62a81d631ae3c4Test
https://portal.findresearcher.sdu.dk/da/publications/08a9e901-9c2e-4d58-beae-d673d2edee93Test

المؤلفون: Larkin, James, Ascierto, Paolo A, Dréno, Brigitte, Atkinson, Victoria, Liszkay, Gabriella, Maio, Michele, Mandalà, Mario, Demidov, Lev, Stroyakovskiy, Daniil, Thomas, Luc, de la Cruz-Merino, Luis, Dutriaux, Caroline, Garbe, Claus, Sovak, Mika A, Chang, Ilsung, Choong, Nicholas, Hack, Stephen P, McArthur, Grant A, Ribas, Antoni

المساهمون: Larkin,J Royal Marsden Hospital, London. Ascierto,PA Istituto Nazionale Tumori Fondazione G. Pascale, Naples,Italy. Dréno,B Hôtel Dieu Place Alexis Ricordeau,Nantes,France. Atkinson,V Princess Alexandra Hospital, Woolloongabba, QLD,Australia. Liszkay,G National Institute of Oncology, Budapest, Hungary. Maio,M Azienda Ospedaliera Universitaria Senese, Siena,Italy. Mandalà,M Papa Giovanni XXIII Hospital, Bergamo,Italy. Demidov,L Blokhin Russian Cancer Research Center, Moscow,Russia. Stroyakovskiy,D Moscow City Oncology Hospital 62, Krasnogorsk, Russia. Thomas,L Centre Hospitalier Lyon Sud, Pierre-Bénite,France. de la Cruz-Merino,L Hospital Universitario Virgen Macarena, Seville, Spain. Dutriaux,C Hôpital Saint André, Bordeaux,France. Garbe,C University of Tübingen, Tübingen, Germany. Sovak,MA, Chang,I, Choong,N, Hack,SP Genentech, South San Francisco. Ribas,A Jonsson Comprehensive Cancer Center at the University of California, Los Angeles., Supported by F. Hoffmann–La Roche/Genentech.

مصطلحات موضوعية: Indoles, Sulfonamides, Proto-oncogene proteins B-raf, MAP quinasa quinasa 1, Azetidines, Piperidinas, Sulfonamidas, Azetidinas, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols, Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Azetines::Azetidines, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Disease-Free Survival, Medical Subject Headings::Check Tags::Female, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, 2-Ring::Indoles, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Survival Analysis::Kaplan-Meier Estimate, Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Serine-Threonine Kinases::Mitogen-Activated Protein Kinase Kinases::MAP Kinase Kinase 1, Medical Subject Headings::Check Tags::Male, Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Histologic Type::Nevi and Melanomas::Melanoma, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged, Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation, 1-Ring::Piperidines, Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Neoplasm Proteins::Oncogene Proteins::Proto-Oncogene Proteins::raf Kinases::Proto-Oncogene Proteins B-raf, Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Sulfur Compounds::Sulfones::Sulfonamides, Medical Subject Headings::Information Science::Information Science::Data Collection::Vital Statistics::Mortality::Survival Rate, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult

وصف الملف: application/pdf

العلاقة: Larkin J, Ascierto PA, Dréno B, Atkinson V, Liszkay G, Maio M, et al. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N. Engl. J. Med. 2014; 371(20):1867-76; http://hdl.handle.net/10668/2159Test

الإتاحة: https://doi.org/10.1056/NEJMoa1408868Test
http://hdl.handle.net/10668/2159Test